Viridian Therapeutics, Inc.\DE (VRDN) Revenue 2016–2025
Viridian Therapeutics, Inc.\DE (VRDN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$70.8MFY2025 · since FY2016: $3.5M → $70.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $70.8M | +23359.9% |
| FY2024 | $302,000 | -3.8% |
| FY2023 | $314,000 | -82.3% |
| FY2022 | $1.8M | -40.2% |
| FY2021 | $3.0M | +182.2% |
| FY2020 | $1.1M | -76.5% |
| FY2019 | $4.5M | -46.8% |
| FY2018 | $8.4M | +109.5% |
| FY2017 | $4.0M | +15.1% |
| FY2016 | $3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice